Table 3.
Characteristics of 5-Year Survivors by Arm
Characteristic | All (N = 85)
|
FOLFOX (n = 49)
|
IFL (n = 13)
|
IROX (n = 18)
|
Other (n = 5)
|
|||||
---|---|---|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | No. | % | No. | % | |
Progression free | 30 | 35 | 17 | 35 | 6 | 46 | 6 | 33 | 1 | 20 |
Resected | 6 | 7 | 5 | 10 | 0 | 0 | 1 | 6 | 0 | 0 |
CR | 22 | 26 | 15 | 31 | 4 | 31 | 3 | 17 | 0 | 0 |
Abbreviations: FOLFOX, oxaliplatin, fluorouracil, and leucovorin; IFL, irinotecan plus bolus fluorouracil and leucovorin; IROX, irinotecan and oxaliplatin; CR, complete response.